Patent: 6,503,713
✉ Email this page to a colleague
Summary for Patent: 6,503,713
| Title: | Methods for identifying RNA binding compounds |
| Abstract: | The present invention relates to methods of screening for compounds that bind RNA molecules. In particular, the methods of the invention comprise screening a library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex. By virtue of the dye label on the target RNA, the support becomes labeled and can be separated from unlabeled solid supports. The present invention further relates to methods of inhibiting an RNA-protein interaction, to methods of screening for compounds that increase or decrease the production of a protein, and to methods of screening for a compound that is capable of treating or preventing a disease whose progression is associated with an in vivo binding of a test compound to a target RNA. |
| Inventor(s): | Rana; Tariq M (Piscataway, NJ) |
| Assignee: | University of Medicine and Dentistry of New Jersey (New Brunswick, NJ) |
| Application Number: | 09/679,451 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,503,713
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2019-10-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
